Safety , Feasibility and Preliminary Efficacy of Remote Ischemic Conditioning in Patients With Aneurysmal Subarachnoid Hemorrhage After Aneurysm Clipping
Remote Ischemic Conditioning for Safety, Feasibility, and Preliminary Efficacy in Patients With Aneurysmal Subarachnoid Hemorrhage After Aneurysm Clipping: An Open-Label, Evaluator-Blinded Randomized Controlled Trial
1 other identifier
interventional
40
1 country
1
Brief Summary
This study was designed to evaluate the safety and efficacy of remote ischemic conditioning (RIC) in patients with aneurysmal subarachnoid hemorrhage (aSAH) following surgical clipping. Aneurysmal subarachnoid hemorrhage is a life-threatening condition that occurs when a cerebral aneurysm ruptures, causing bleeding into the subarachnoid space. Surgical clipping of the aneurysm is a standard procedure used to stop the bleeding and prevent re-rupture, thereby stabilizing the patient's condition. Remote ischemic conditioning (RIC) is a non-invasive treatment that involves using a blood pressure cuff to induce brief, temporary cycles of ischemia and reperfusion in a limb. Research suggests that this process may confer systemic protective effects, potentially improving recovery from brain injury or surgery. Although RIC has shown potential to improve outcomes in patients with other neurological conditions, its effect on patients with aSAH who undergo surgical clipping remains unclear. This study will evaluate whether RIC can reduce complications, improve neurological function, and enhance overall recovery in these patients. The findings will help determine whether RIC should be incorporated into the standard treatment regimen for aSAH.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 5, 2025
CompletedFirst Posted
Study publicly available on registry
February 11, 2025
CompletedStudy Start
First participant enrolled
March 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2026
CompletedSeptember 9, 2025
August 1, 2025
10 months
February 5, 2025
September 8, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Proportion of mRS (0-2)
Modified Rankin Scale, mRS; min:0, max:6; A smaller score indicates a better prognosis.
90±7 days post-enrollment in the study
incidence rate of RIC adverse events
RIC adverse events mainly include: limb pain, skin damage, deep vein thrombosis, transient hypertension, etc.
From enrollment to the end of RIC at 1 week
Secondary Outcomes (3)
mRS Score as ordinal variable
7±1 days post-enrollment in the study
mRS Score as ordinal variable
30±7 days post-enrollment in the study
incidence rate of aSAH complications
From enrollment to 90 days post-enrollment
Study Arms (2)
control group
OTHERGuideline-based therapy
RIC Group
EXPERIMENTALGuideline-based therapy + RIC (200 mmHg, bid, 7d)
Interventions
Remote ischemic conditioning (RIC) was administered twice daily to the unilateral lower limb using a blood pressure cuff inflated to 200 mmHg for 7 consecutive days post-clipping
Eligibility Criteria
You may qualify if:
- Imaging examination confirmed aneurysmal subarachnoid hemorrhage.
- Responsible aneurysms received craniotomy clipping within 24 hours.
- ≤ age ≤80 years old.
- Informed consent of the participant or legally authorized representative
You may not qualify if:
- Patients with other types of cerebral hemorrhage.
- Prior neurological impairment (mRS Score \>1) or mental illness may confuse neurological or functional assessment.
- Severe comorbidities with a life expectancy of less than 90 days.
- Refractory hypertension (systolic blood pressure 180\>mmHg or diastolic blood pressure 110\>mmHg).
- RIC contraindications: severe soft tissue injury of lower limbs.
- Simultaneously participate in another research program to study a different experimental therapy.
- Any condition that the investigator believes may increase the patient's risk.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Tiantan Hospital
Beijing, Beijing Municipality, 100000, China
Related Publications (1)
Xu L, Jin T, Niu H, Yin Y, Yan K, Guan H, Liu A. Remote ischemic conditioning for safety, feasibility and preliminary efficacy of patients with aneurysmal subarachnoid hemorrhage after aneurysm clipping, design, and protocol for an open-label, evaluator blinding randomized controlled trial. Front Neurol. 2025 Nov 20;16:1650773. doi: 10.3389/fneur.2025.1650773. eCollection 2025.
PMID: 41356238DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 5, 2025
First Posted
February 11, 2025
Study Start
March 10, 2025
Primary Completion
December 30, 2025
Study Completion
March 30, 2026
Last Updated
September 9, 2025
Record last verified: 2025-08